CX Interviews
CX 2019: Highlights from the inaugural iWounds Workshop
Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and [...]
Hear the latest thoughts on paclitaxel from global experts: their current practice and patient conversations
Following the latest information presented at the Charing Cross International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al, JAHA), hear from a multi-specialty panel of global experts who are discussing their [...]
Don’t miss: The influence of hyperglycaemia on spinal cord injury
Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.” Hiramoto is presenting [...]
CX 2019: Why a signed consent form “is not consent”
Jonathan Beard, (Sheffield, UK), discusses the current medicolegal issues in the field and explains how vascular surgeons can become “the fall-guy for the inadequacies of other clinicians”. Beard touches on how the threshold for [...]
News from CX 2019: Evidence supports safety of paclitaxel-coated devices
At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the [...]
Breaking news from CX 2019: Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level data
There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available [...]